Double action pain relief

MAXIGESIC® is a unique, patented combination of paracetamol and ibuprofen that provides fast, effective double action pain relief from a wide range of pain

Paracetamol acts mainly in the brain, while ibuprofen targets the production of pain chemicals throughout the body and reduces inflammation.

How it works

Put Maxigesic® to the test for your pain

Better, faster pain relief than paracetamol or ibuprofen alone1

Proven to provide more effective pain relief in a key study

78 Percent Better Faster
More effective relief than Paracetamol1
36 Percent Better Faster
More effective relief than Ibuprofen1
Faster Onset Of Pain Relief
Faster onset of meaningful pain relief than paracetamol or ibuprofen alone1

A key clinical study of post-operative pain relief after removal of 2-4 wisdom teeth shows that a full daily dose of Maxigesic provides more effective and faster onset of meaningful pain relief than the equivalent dose of paracetamol or ibuprofen, given in 4 divided doses.1

Breaking Out of Pain

For the temporary relief of
the pain associated with

  • Headache
  • Migraine headache
  • Tension headache
  • Muscular pain
  • Backache
  • Period pain
  • Mild osteoarthritis
  • Rheumatic pain
  • Toothache
  • Dental procedures
  • Fever
  • Tennis elbow
  • Aches and pain from colds and flu
  • Sinus pain
  • Sore throat
Shop now

Put Maxigesic® to the test
for your pain

Shop Now

For your winter ills and chills,
try Maxigesic® Cold & Flu Hot Drink

Cold Flu Hot Drink Packs
Shop Now
Always read the label and follow the directions for use. Incorrect use could be harmful.

Ref 1. Daniels et al (2018). “Analgesic Efficacy of an Acetaminophen/Ibuprofen Fixed-dose Combination in Moderate to Severe Postoperative Dental Pain: A Randomized, Double-blind, Parallel-group, Placebo-controlled Trial”, Clinical Therapeutics 40 (10): 1765-1776. Result achieved in a trial of post-operative pain relief after removal of at least 2 impacted third molars using Maxigesic US fixed-dose combination (Paracetamol 975mg/Ibuprofen 292.5mg) compared with Paracetamol 975mg or Ibuprofen 292.5mg alone 4 times a day (Paracetamol 3900mg or Ibuprofen 1170mg per day). Study results assessed on the intent-to-treat (ITT) population with adjustment for the use of rescue medication. The Australian Maxigesic combination is bioequivalent to the US Maxigesic FDC in clinically relevant conditions (Aitken et al., J Bioequiv Availab 2018, 10:5). Research sponsored by AFT Pharmaceuticals. AFT Pharmaceuticals Pty Ltd, Sydney. Patent No. 2005260243